Free Trial

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$5.35 -0.02 (-0.37%)
As of 04:00 PM Eastern

AVR vs. CBLL, EMBC, BFLY, DCTH, AVNS, BVS, AXGN, KIDS, SMLR, and NPCE

Should you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include CeriBell (CBLL), Embecta (EMBC), Butterfly Network (BFLY), Delcath Systems (DCTH), Avanos Medical (AVNS), Bioventus (BVS), AxoGen (AXGN), OrthoPediatrics (KIDS), Semler Scientific (SMLR), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry.

Anteris Technologies Global vs.

Anteris Technologies Global (NASDAQ:AVR) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking.

CeriBell received 6 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. Likewise, 100.00% of users gave CeriBell an outperform vote while only 80.00% of users gave Anteris Technologies Global an outperform vote.

CompanyUnderperformOutperform
Anteris Technologies GlobalOutperform Votes
4
80.00%
Underperform Votes
1
20.00%
CeriBellOutperform Votes
10
100.00%
Underperform Votes
No Votes

Company Net Margins Return on Equity Return on Assets
Anteris Technologies GlobalN/A N/A N/A
CeriBell N/A N/A N/A

Anteris Technologies Global currently has a consensus price target of $16.50, suggesting a potential upside of 208.41%. CeriBell has a consensus price target of $32.50, suggesting a potential upside of 83.41%. Given Anteris Technologies Global's higher possible upside, research analysts plainly believe Anteris Technologies Global is more favorable than CeriBell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
CeriBell
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Anteris Technologies Global had 1 more articles in the media than CeriBell. MarketBeat recorded 6 mentions for Anteris Technologies Global and 5 mentions for CeriBell. CeriBell's average media sentiment score of 0.90 beat Anteris Technologies Global's score of 0.74 indicating that CeriBell is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Anteris Technologies Global
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CeriBell
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$2.70M71.38N/AN/AN/A
CeriBell$71.54M8.95N/AN/AN/A

Summary

CeriBell beats Anteris Technologies Global on 5 of the 8 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

MetricAnteris Technologies GlobalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$192.93M$9.40B$5.57B$8.66B
Dividend YieldN/A1.26%5.27%4.19%
P/E RatioN/A21.1427.2020.17
Price / Sales71.3848.06412.92161.90
Price / CashN/A19.6738.2534.64
Price / BookN/A5.257.114.72
Net IncomeN/A$284.66M$3.23B$247.80M
7 Day Performance19.69%-1.02%4.61%3.36%
1 Month Performance27.08%-2.05%13.35%9.71%
1 Year PerformanceN/A-20.16%31.75%14.41%

Anteris Technologies Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
N/A$5.35
-0.4%
$16.50
+208.4%
N/A$192.93M$2.70M0.00138News Coverage
Lockup Expiration
CBLL
CeriBell
2.645 of 5 stars
$17.02
-1.0%
$32.50
+91.0%
N/A$615.15M$71.54M0.00N/APositive News
EMBC
Embecta
4.7162 of 5 stars
$10.45
-0.9%
$19.33
+85.0%
-20.3%$610.73M$1.08B10.451,900
BFLY
Butterfly Network
1.9339 of 5 stars
$2.45
-6.8%
$4.00
+63.1%
+176.8%$606.35M$85.63M-5.33460News Coverage
DCTH
Delcath Systems
3.4659 of 5 stars
$17.06
+5.4%
$24.00
+40.7%
+143.5%$594.13M$53.85M-12.6460
AVNS
Avanos Medical
2.2841 of 5 stars
$12.62
+1.5%
N/A-36.1%$583.60M$689.20M37.124,040News Coverage
BVS
Bioventus
2.558 of 5 stars
$6.56
+0.5%
$14.33
+118.5%
+6.2%$538.87M$567.70M-10.751,200Positive News
AXGN
AxoGen
2.8213 of 5 stars
$10.90
-0.5%
$22.20
+103.7%
+49.4%$496.43M$194.52M-34.06450
KIDS
OrthoPediatrics
4.3186 of 5 stars
$20.36
-0.4%
$35.83
+76.0%
-28.6%$494.48M$212.45M-16.55200Positive News
SMLR
Semler Scientific
2.7297 of 5 stars
$40.08
-3.0%
$71.00
+77.1%
+7.5%$460.80M$49.23M8.16120Options Volume
NPCE
NeuroPace
2.3938 of 5 stars
$13.11
+5.2%
$15.50
+18.2%
+99.8%$430.00M$84.31M-13.11170Trending News
Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NASDAQ:AVR) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners